Alternative uses of dextranomer/hyaluronic acid copolymer: The efficacy of bladder neck injection for urinary incontinence

Rosalia Misseri, Anthony J. Casale, Mark P. Cain, Richard C. Rink, Joao L. Pippi-Salle

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose: Urinary continence in children with neuropathic bladder and other urological disorders depends on a bladder with adequate low pressure storage capacity and a competent outlet. Various procedures are performed with the goal of achieving continence in these patients. Recently, dextranomer/hyaluronic acid copolymer (Dx/H) has been introduced for the correction of vesicoureteral reflux. We evaluated the efficacy of submucosal bladder neck (BN) injection of Dx/H for urethral incontinence in children. Materials and Methods: We retrospectively reviewed continence status after Dx/H injection into the BN for incontinence. Parameters examined include gender, underlying disease, prior BN surgery and means of emptying the bladder. Continence was described by the patients and/or their parents as unchanged (no change in requirements for diapers or pads), improved (longer dry intervals or requiring fewer pads/diapers) or dry (requiring no pads and dry in underwear). Results: A total of 6 males and 10 females underwent injections for treatment of incontinence. Mean followup was 9.5 months (range 3 to 24). Volumes injected ranged from 0.8 to 4.4 ml (mean 1.88). Of the patients 3 achieved dryness after injection, all of whom had catheterizabile urinary stomas and two-thirds had undergone bladder augmentations. All 5 patients who improved had undergone augmentation and had catheterizable channels. No improvement was seen in 8 patients. Conclusions: Injection at the BN is well tolerated and relatively easy to perform. Success rates may be better in females and in patients with neuropathic incontinence. Despite limited success it remains an option for all patients who are poor surgical candidates and those who want to avoid extensive BN reconstruction.

Original languageEnglish
Pages (from-to)1691-1694
Number of pages4
JournalJournal of Urology
Volume174
Issue number4 II
DOIs
StatePublished - Oct 2005

Fingerprint

Urinary Incontinence
Urinary Bladder
Injections
Urinary Bladder Diseases
Neurogenic Urinary Bladder
Vesico-Ureteral Reflux
dextranomer-hyaluronic acid copolymer
Parents
Pressure

Keywords

  • Dextranomer-hyaluronic acid copolymer
  • Injections
  • Urinary incontinence

ASJC Scopus subject areas

  • Urology

Cite this

Alternative uses of dextranomer/hyaluronic acid copolymer : The efficacy of bladder neck injection for urinary incontinence. / Misseri, Rosalia; Casale, Anthony J.; Cain, Mark P.; Rink, Richard C.; Pippi-Salle, Joao L.

In: Journal of Urology, Vol. 174, No. 4 II, 10.2005, p. 1691-1694.

Research output: Contribution to journalArticle

Misseri, Rosalia ; Casale, Anthony J. ; Cain, Mark P. ; Rink, Richard C. ; Pippi-Salle, Joao L. / Alternative uses of dextranomer/hyaluronic acid copolymer : The efficacy of bladder neck injection for urinary incontinence. In: Journal of Urology. 2005 ; Vol. 174, No. 4 II. pp. 1691-1694.
@article{110a43e844a2472192b1adf25db57b20,
title = "Alternative uses of dextranomer/hyaluronic acid copolymer: The efficacy of bladder neck injection for urinary incontinence",
abstract = "Purpose: Urinary continence in children with neuropathic bladder and other urological disorders depends on a bladder with adequate low pressure storage capacity and a competent outlet. Various procedures are performed with the goal of achieving continence in these patients. Recently, dextranomer/hyaluronic acid copolymer (Dx/H) has been introduced for the correction of vesicoureteral reflux. We evaluated the efficacy of submucosal bladder neck (BN) injection of Dx/H for urethral incontinence in children. Materials and Methods: We retrospectively reviewed continence status after Dx/H injection into the BN for incontinence. Parameters examined include gender, underlying disease, prior BN surgery and means of emptying the bladder. Continence was described by the patients and/or their parents as unchanged (no change in requirements for diapers or pads), improved (longer dry intervals or requiring fewer pads/diapers) or dry (requiring no pads and dry in underwear). Results: A total of 6 males and 10 females underwent injections for treatment of incontinence. Mean followup was 9.5 months (range 3 to 24). Volumes injected ranged from 0.8 to 4.4 ml (mean 1.88). Of the patients 3 achieved dryness after injection, all of whom had catheterizabile urinary stomas and two-thirds had undergone bladder augmentations. All 5 patients who improved had undergone augmentation and had catheterizable channels. No improvement was seen in 8 patients. Conclusions: Injection at the BN is well tolerated and relatively easy to perform. Success rates may be better in females and in patients with neuropathic incontinence. Despite limited success it remains an option for all patients who are poor surgical candidates and those who want to avoid extensive BN reconstruction.",
keywords = "Dextranomer-hyaluronic acid copolymer, Injections, Urinary incontinence",
author = "Rosalia Misseri and Casale, {Anthony J.} and Cain, {Mark P.} and Rink, {Richard C.} and Pippi-Salle, {Joao L.}",
year = "2005",
month = "10",
doi = "10.1097/01.ju.0000179253.13807.82",
language = "English",
volume = "174",
pages = "1691--1694",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "4 II",

}

TY - JOUR

T1 - Alternative uses of dextranomer/hyaluronic acid copolymer

T2 - The efficacy of bladder neck injection for urinary incontinence

AU - Misseri, Rosalia

AU - Casale, Anthony J.

AU - Cain, Mark P.

AU - Rink, Richard C.

AU - Pippi-Salle, Joao L.

PY - 2005/10

Y1 - 2005/10

N2 - Purpose: Urinary continence in children with neuropathic bladder and other urological disorders depends on a bladder with adequate low pressure storage capacity and a competent outlet. Various procedures are performed with the goal of achieving continence in these patients. Recently, dextranomer/hyaluronic acid copolymer (Dx/H) has been introduced for the correction of vesicoureteral reflux. We evaluated the efficacy of submucosal bladder neck (BN) injection of Dx/H for urethral incontinence in children. Materials and Methods: We retrospectively reviewed continence status after Dx/H injection into the BN for incontinence. Parameters examined include gender, underlying disease, prior BN surgery and means of emptying the bladder. Continence was described by the patients and/or their parents as unchanged (no change in requirements for diapers or pads), improved (longer dry intervals or requiring fewer pads/diapers) or dry (requiring no pads and dry in underwear). Results: A total of 6 males and 10 females underwent injections for treatment of incontinence. Mean followup was 9.5 months (range 3 to 24). Volumes injected ranged from 0.8 to 4.4 ml (mean 1.88). Of the patients 3 achieved dryness after injection, all of whom had catheterizabile urinary stomas and two-thirds had undergone bladder augmentations. All 5 patients who improved had undergone augmentation and had catheterizable channels. No improvement was seen in 8 patients. Conclusions: Injection at the BN is well tolerated and relatively easy to perform. Success rates may be better in females and in patients with neuropathic incontinence. Despite limited success it remains an option for all patients who are poor surgical candidates and those who want to avoid extensive BN reconstruction.

AB - Purpose: Urinary continence in children with neuropathic bladder and other urological disorders depends on a bladder with adequate low pressure storage capacity and a competent outlet. Various procedures are performed with the goal of achieving continence in these patients. Recently, dextranomer/hyaluronic acid copolymer (Dx/H) has been introduced for the correction of vesicoureteral reflux. We evaluated the efficacy of submucosal bladder neck (BN) injection of Dx/H for urethral incontinence in children. Materials and Methods: We retrospectively reviewed continence status after Dx/H injection into the BN for incontinence. Parameters examined include gender, underlying disease, prior BN surgery and means of emptying the bladder. Continence was described by the patients and/or their parents as unchanged (no change in requirements for diapers or pads), improved (longer dry intervals or requiring fewer pads/diapers) or dry (requiring no pads and dry in underwear). Results: A total of 6 males and 10 females underwent injections for treatment of incontinence. Mean followup was 9.5 months (range 3 to 24). Volumes injected ranged from 0.8 to 4.4 ml (mean 1.88). Of the patients 3 achieved dryness after injection, all of whom had catheterizabile urinary stomas and two-thirds had undergone bladder augmentations. All 5 patients who improved had undergone augmentation and had catheterizable channels. No improvement was seen in 8 patients. Conclusions: Injection at the BN is well tolerated and relatively easy to perform. Success rates may be better in females and in patients with neuropathic incontinence. Despite limited success it remains an option for all patients who are poor surgical candidates and those who want to avoid extensive BN reconstruction.

KW - Dextranomer-hyaluronic acid copolymer

KW - Injections

KW - Urinary incontinence

UR - http://www.scopus.com/inward/record.url?scp=24944573555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944573555&partnerID=8YFLogxK

U2 - 10.1097/01.ju.0000179253.13807.82

DO - 10.1097/01.ju.0000179253.13807.82

M3 - Article

C2 - 16148683

AN - SCOPUS:24944573555

VL - 174

SP - 1691

EP - 1694

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 4 II

ER -